
Admenta 5mg (Memantine)
Admenta 5 mg is the introductory dose of memantine, designed for gradual initiation in patients with moderate Alzheimer’s disease. As an NMDA receptor antagonist, it helps regulate excitotoxic activity in the brain, paving the way for cognitive support and tolerance before escalating to therapeutic levels under clinical oversight.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
✅ Key Benefits
-
Facilitates safe dose escalation in early memantine therapy
-
Helps manage cognition and memory stabilization
-
May slow progression of functional decline when maintained
-
Minimizes side effects at lower initial dosing
-
Convenient starting tablet for dose tapering and adjustment
🎯 How to Use
-
Take once daily with or without food as directed
-
Use under medical supervision—typically increased to 10 mg after tolerance is established
-
Regular follow-up is recommended to assess efficacy and monitor side effects
-
Avoid abrupt discontinuation or exceeding prescribed dosage
⚠️ Precautions
-
Prescription-only; use only with neurologist or specialist guidance
-
Monitor renal function for appropriate dosing and safety
-
Be cautious when using other NMDA antagonists or glutamatergic agents
-
Avoid abrupt dose changes without professional consultation
🤕 Possible Side Effects
-
Common: dizziness, headache, slight confusion, constipation
-
Less Common: fatigue, mild hallucinations, hypertension
-
Rare but Serious: allergic reactions or worsening cognitive symptoms—report to your doctor immediately
🎁 My Health Solutions Offers
-
💰 Up to 50% OFF on prescription cognitive health support
-
🚚 Free shipping for orders over ₹1999
-
📦 Secure, discreet packaging for patient privacy
-
🔐 Multiple secure payment options & quick checkout
❓ Frequently Asked Questions (FAQs)
Q. Who is Admenta 5 mg intended for?
Ideal for patients beginning memantine therapy to build tolerance to the medication before escalating to full therapeutic dose.
Q. When might I notice effects?
Initial stabilization of cognition or functional slow-down may appear within 1–3 weeks; full effect often assessed at higher dosage.
Q. Is monitoring required during titration?
Yes—regular follow-up on renal status, cognitive function, and side effects is recommended during dose escalation.
Q. Can it be used with other Alzheimer’s medications?
Yes—commonly used in combination with cholinesterase inhibitors or cognitive enhancers under medical supervision.
Unit | 30 Tablets, 60 Tablets, 90 Tablets |
---|
Reviews
There are no reviews yet.